Management of metabolic adverse events of targeted therapies and immune checkpoint inhibitors in cancer patients: an Associazione Italiana Oncologia Medica (AIOM)/Associazione Medici Diabetologi (AMD)/Società Italiana Farmacologia (SIF) multidisciplinary consensus position paper.
Saved in:
| Title: | Management of metabolic adverse events of targeted therapies and immune checkpoint inhibitors in cancer patients: an Associazione Italiana Oncologia Medica (AIOM)/Associazione Medici Diabetologi (AMD)/Società Italiana Farmacologia (SIF) multidisciplinary consensus position paper. |
|---|---|
| Authors: | Silvestris N; IRCCS Istituto Tumori 'Giovanni Paolo II' of Bari, Italy; Department of Biomedical Sciences and Human Oncology, University of Bari 'Aldo Moro', Bari, Italy. Electronic address: n.silvestris@oncologico.bari.it., Argentiero A; IRCCS Istituto Tumori 'Giovanni Paolo II' of Bari, Italy., Beretta GD; Medical Oncology Department, Humanitas Gavazzeni, Bergamo, Italy., Di Bartolo P; Diabetology Unit, Rete Clinica di Diabetologia Aziendale - Dipartimento, Internistico di Ravenna - AUSL Romagna, Ravenna, Italy., Montagnani M; Department of Biomedical Sciences and Human Oncology, University of Bari 'Aldo Moro', Bari, Italy., Danesi R; Unit of Clinical Pharmacology and Pharmacogenetics, Department of Clinical and Experimental Medicine, University of Pisa, Italy., Ferrari P; Palliative Care Unit, Istituti Clinici Scientifici Maugeri SPA SB, IRCCS (PV), Italy., D'Oronzo S; IRCCS Istituto Tumori 'Giovanni Paolo II' of Bari, Italy; Department of Biomedical Sciences and Human Oncology, University of Bari 'Aldo Moro', Bari, Italy., Gori S; Oncologia Medica, IRCCS Ospedale Don Calabria-Sacro Cuore di Negrar, Verona, Italy., Russo A; Department of Surgical, Oncological and Oral Sciences, Section of Medical Oncology, University of Palermo, Italy., Acquati S; Endocrinology Unit, Ospedale Pierantoni-Morgagni, Forlì, Italy., Gallo M; Oncological Endocrinology Unit, Department of Medical Sciences, University of Torino, AOU Città della Salute e della Scienza di Torino, Torino, Italy. |
| Source: | Critical reviews in oncology/hematology [Crit Rev Oncol Hematol] 2020 Oct; Vol. 154, pp. 103066. Date of Electronic Publication: 2020 Aug 15. |
| Publication Type: | Journal Article; Review; Consensus Statement |
| Journal Info: | Publisher: Elsevier Scientific Publishers Country of Publication: Netherlands NLM ID: 8916049 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0461 (Electronic) Linking ISSN: 10408428 NLM ISO Abbreviation: Crit Rev Oncol Hematol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
